×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Blue Water changes tides again, dropping all vaccine programs and 6 approved drugs
Fierce Biotech
With a new CEO in charge, Blue Water is reprioritizing its pipeline, dropping six-FDA approved drugs and a wide-ranging vaccine portfolio.
6 months ago
Blue Water rebrands to Onconetix as it drops vaccine pipeline - Cincinnati Business Courier
The Business Journals
Blue Water Biotech is now operating as Onconetix following its mid-December purchase of Proteomedix AG, a Swiss-based private,...
4 months ago
$11 million NIH grant awarded for five-year investigation of novel oral chlamydia vaccine
UT Health San Antonio
The study of a novel oral vaccine that could protect against chlamydia infection received more than $11 million in National Institutes of...
3 weeks ago
Proteomedix acquired by Blue Water Biotech to form Onconetix
The Pharma Letter
Shares of Blue Water Biotech (Nasdaq: BWV) were down 11.8% at $0.24 pre-market, after it announced the acquisition of Proteomedix AG,...
5 months ago
Blue Water agrees to buy Veru's Entadfi capsules business
Pharmaceutical Technology
Entadfi combines finasteride and tadalafil to provide an effective treatment option for benign prostatic hyperplasia. April 21, 2023.
13 months ago
Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment ...
GlobeNewswire
CINCINNATI, Ohio, June 14, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV), a biotechnology company spanning multiple...
11 months ago
Blue Water Biotech names new CEO, CFO as company faces dual Nasdaq delisting notices - Cincinnati Business Courier
The Business Journals
The company's new leadership will be immediately tasked with addressing a pair of Nasdaq delisting notices received in recent weeks.
7 months ago
Blue Water Vaccines stock rockets over 400% following $40M IPO (BWV)
Seeking Alpha
Blue Water Vaccines (BWV) stock soared over 400% after holding an initial public offering that raised $20M.Shares of the vaccine developer...
27 months ago
Blue Water buys enlarged prostate drug Entadfi from Veru for up to $100M
Fierce Pharma
Veru has sold its drug for enlarged prostate, Entadfi, to Blue Water Vaccines. The deal is for $20M up front, plus an additional $80M in...
13 months ago
Oral Chlamydia Vaccine Candidate Begins Development — Precision Vaccinations News
Precision Vaccinations News
Blue Water Vaccines Inc. announced the signing of an exclusive, global license agreement to develop a live attenuated, oral Chlamydia...
18 months ago